SOMAKIT TOC

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug SOMAKIT TOC contains one active pharmaceutical ingredient (API):

1 Gallium ⁶⁸Ga edotreotide UNII U194AS08HZ - EDOTREOTIDE

Gallium ⁶⁸Ga edotreotide binds to somatostatin receptors, with highest affinity (Ki = 2.5 ± 0.5 nanomolar) for subtype 2 receptors (sstr2). Gallium ⁶⁸Ga edotreotide binds to cells that express somatostatin receptors including malignant neuroendocrine cells, which overexpress sstr2 receptors. Read about Gallium ⁶⁸Ga edotreotide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX09		V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1734645
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1161141001
Country: FR	Base de données publique des médicaments	Identifier(s): 65028549
Country: IT	Agenzia del Farmaco	Identifier(s): 045231014
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1081824
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100381890